Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
$62.43
+2.8%
$56.73
$38.18
$62.74
$99.46B1.431.63 million shs1.75 million shs
Corning Incorporated stock logo
GLW
Corning
$55.77
+3.2%
$51.14
$37.18
$56.25
$46.27B1.115.24 million shs8.08 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.32
+0.7%
$24.20
$20.92
$31.54
$142.93B0.5841.83 million shs42.04 million shs
Seagen Inc. stock logo
SGEN
Seagen
$228.74
$228.74
$123.77
$228.96
$42.93B0.321.48 million shs86 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
+2.80%+5.20%+15.50%+19.09%+48.25%
Corning Incorporated stock logo
GLW
Corning
+3.19%+5.30%+7.67%+27.04%+26.55%
Pfizer Inc. stock logo
PFE
Pfizer
+0.79%+2.99%+5.34%+11.07%-14.13%
Seagen Inc. stock logo
SGEN
Seagen
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
4.433 of 5 stars
2.34.00.82.83.72.51.9
Corning Incorporated stock logo
GLW
Corning
3.5865 of 5 stars
2.43.01.70.03.82.51.9
Pfizer Inc. stock logo
PFE
Pfizer
4.9784 of 5 stars
3.23.04.24.54.01.73.1
Seagen Inc. stock logo
SGEN
Seagen
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
2.53
Moderate Buy$59.64-4.46% Downside
Corning Incorporated stock logo
GLW
Corning
2.85
Moderate Buy$57.453.02% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.45
Hold$28.5512.74% Upside
Seagen Inc. stock logo
SGEN
Seagen
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest BAM, PFE, SGEN, and GLW Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/17/2025
Corning Incorporated stock logo
GLW
Corning
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$52.00 ➝ $62.00
7/15/2025
Corning Incorporated stock logo
GLW
Corning
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOutperform ➝ Outperform$52.00 ➝ $59.00
7/11/2025
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetUnderweight ➝ Underweight$55.00 ➝ $57.00
7/11/2025
Corning Incorporated stock logo
GLW
Corning
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$52.00 ➝ $60.00
7/9/2025
Corning Incorporated stock logo
GLW
Corning
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$54.00 ➝ $57.00
7/8/2025
Corning Incorporated stock logo
GLW
Corning
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$44.00 ➝ $50.00
7/8/2025
Corning Incorporated stock logo
GLW
Corning
Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform
6/30/2025
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$60.00
6/18/2025
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform ➝ Outperform$68.00 ➝ $72.00
5/29/2025
Pfizer Inc. stock logo
PFE
Pfizer
Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold$28.00 ➝ $25.00
5/23/2025
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetUnderweight ➝ Underweight$54.00 ➝ $55.00
(Data available from 7/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
$3.98B25.68$5.78 per share10.80$7.80 per share8.00
Corning Incorporated stock logo
GLW
Corning
$13.12B3.64$3.68 per share15.17$12.93 per share4.31
Pfizer Inc. stock logo
PFE
Pfizer
$63.63B2.26$4.40 per share5.76$15.62 per share1.62
Seagen Inc. stock logo
SGEN
Seagen
$2.30B18.66N/AN/A$15.10 per share15.15
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
$541M$1.4144.2731.372.3555.26%52.70%35.46%8/6/2025 (Estimated)
Corning Incorporated stock logo
GLW
Corning
$506M$0.52107.2520.431.463.34%16.47%6.64%7/29/2025 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$8.03B$1.3818.358.360.9212.62%20.33%8.53%8/5/2025 (Estimated)
Seagen Inc. stock logo
SGEN
Seagen
-$610.31M-$4.01N/AN/AN/A-32.61%-28.06%-20.92%N/A

Latest BAM, PFE, SGEN, and GLW Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2025Q2 2025
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
$0.41N/AN/AN/A$1.29 billionN/A
8/5/2025Q2 2025
Pfizer Inc. stock logo
PFE
Pfizer
$0.57N/AN/AN/A$13.43 billionN/A
7/29/2025Q2 2025
Corning Incorporated stock logo
GLW
Corning
$0.57N/AN/AN/A$3.84 billionN/A
5/6/2025Q1 2025
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
$0.40$0.40N/A$0.36$1.29 billion$1.04 billion
4/29/2025Q1 2025
Corning Incorporated stock logo
GLW
Corning
$0.51$0.54+$0.03$0.18$3.63 billion$3.68 billion
4/29/2025Q1 2025
Pfizer Inc. stock logo
PFE
Pfizer
$0.67$0.92+$0.25$0.52$14.43 billion$13.72 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
$1.752.80%N/A124.11%2 Years
Corning Incorporated stock logo
GLW
Corning
$1.122.01%N/A215.38%N/A
Pfizer Inc. stock logo
PFE
Pfizer
$1.726.79%N/A124.64%16 Years
Seagen Inc. stock logo
SGEN
Seagen
N/AN/AN/AN/AN/A

Latest BAM, PFE, SGEN, and GLW Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/26/2025
Corning Incorporated stock logo
GLW
Corning
quarterly$0.282.2%8/29/20258/29/20259/29/2025
6/25/2025
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.437.08%7/25/20257/25/20259/2/2025
5/6/2025
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
quarterly$0.43753.25%5/30/20255/30/20256/30/2025
5/2/2025
Corning Incorporated stock logo
GLW
Corning
quarterly$0.282.4%5/30/20255/30/20256/27/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
0.07
1.31
1.31
Corning Incorporated stock logo
GLW
Corning
0.62
1.69
1.05
Pfizer Inc. stock logo
PFE
Pfizer
0.64
1.26
0.96
Seagen Inc. stock logo
SGEN
Seagen
N/A
2.67
2.12

Institutional Ownership

CompanyInstitutional Ownership
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
68.41%
Corning Incorporated stock logo
GLW
Corning
69.80%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%
Seagen Inc. stock logo
SGEN
Seagen
84.26%

Insider Ownership

CompanyInsider Ownership
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
11.00%
Corning Incorporated stock logo
GLW
Corning
0.40%
Pfizer Inc. stock logo
PFE
Pfizer
0.06%
Seagen Inc. stock logo
SGEN
Seagen
25.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
250,0001.64 billion1.46 billionOptionable
Corning Incorporated stock logo
GLW
Corning
56,300856.47 million853.05 millionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
81,0005.69 billion5.68 billionOptionable
Seagen Inc. stock logo
SGEN
Seagen
3,256187.70 million139.08 millionOptionable

Recent News About These Companies

Merck in "advanced talks" for $40bn Seagen bid; report
Seagen posts breast cancer win ahead of Pfizer takeover
Is Merck planning a $30bn-plus move for Seagen?
Pfizer raises guidance as COVID franchise drives Q3 beat
Franklin Biotechnology Discovery C
Seagen wins Enhertu patent dispute with Daiichi Sankyo
Pfizer: Turning The Corner (Rating Upgrade)
HER2 heats up as Seagen licenses RemeGen ADC for $2.6bn
MRNA Feb 2024 64.000 put
MRNA Feb 2024 77.000 call
MRNA Feb 2024 67.000 put

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Brookfield Asset Management stock logo

Brookfield Asset Management NYSE:BAM

$62.43 +1.69 (+2.78%)
Closing price 07/23/2025 03:59 PM Eastern
Extended Trading
$62.74 +0.31 (+0.50%)
As of 06:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Brookfield Asset Management Ltd. is a real estate investment firm specializing in alternative asset management services. Its renewable power and transition business includes the operates in the hydroelectric, wind, solar, distributed generation, and sustainable solution sector. The company's infrastructure business engages in the utilities, transport, midstream, and data infrastructure sectors. In addition, its private equity business offers industrial, infrastructure, and business services sectors; and real estate business, which includes housing, logistics, hospitality, science and innovation, office, and retail sectors. Further, it provides credit business; and insurance solution in the reinsurance, annuities, operating platform, and investment solutions sectors. Brookfield Asset Management Ltd. was incorporated in 2022 and is headquartered in Toronto, Canada.

Corning stock logo

Corning NYSE:GLW

$55.77 +1.75 (+3.24%)
Closing price 07/23/2025 03:59 PM Eastern
Extended Trading
$55.78 +0.00 (+0.01%)
As of 05:20 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Corning Incorporated engages in the display technologies, optical communications, environmental technologies, specialty materials, and life sciences businesses in the United States and internationally. The company's Display Technologies segment offers glass substrates for flat panel displays, including liquid crystal displays and organic light-emitting diodes that are used in televisions, notebook computers, desktop monitors, tablets, and handheld devices. Its Optical Communications segment provides optical fibers and cables; and hardware and equipment products, such as cable assemblies, fiber optic hardware and connectors, optical components and couplers, closures, network interface devices, and other accessories for the telecommunications industry, businesses, governments, and individuals. The company's Specialty Materials segment manufactures products that offer material formulations for glass, glass ceramics, crystals, precision metrology instruments, and software, as well as glass wafers and substrates, tinted sunglasses, and radiation shielding products for various markets comprising mobile consumer electronics, semiconductor equipment optics and consumables, aerospace and defense optics, radiation shielding products, sunglasses, and telecommunications components. Its Environmental Technologies segment provides ceramic substrates and filter products for emissions control in mobile, gasoline, and diesel applications. The company's Life Sciences segment offers laboratory products, including consumables, such as plastic vessels, liquid handling plastics, specialty surfaces, cell culture media, and serum, as well as general labware, and glassware and equipment under the Corning, Pyrex, Falcon, and Axygen brands. The company was formerly known as Corning Glass Works and changed its name to Corning Incorporated in April 1989. Corning Incorporated was founded in 1851 and is headquartered in Corning, New York.

Pfizer stock logo

Pfizer NYSE:PFE

$25.32 +0.18 (+0.73%)
Closing price 07/23/2025 03:59 PM Eastern
Extended Trading
$25.42 +0.10 (+0.40%)
As of 06:24 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Seagen stock logo

Seagen NASDAQ:SGEN

Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. It offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of adult patients with advanced or metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer. The company also develops TIVDAK for metastatic cervical cancer and other solid tumors; Ladiratuzumab Vedotin, an ADC targeting LIV-1 for metastatic breast cancer and solid tumors; Disitamab Vedotin, a novel HER2-targeted ADC; and SEA-TGT and SEA-CD70 for various cancer diseases. It has collaboration agreements with Takeda Pharmaceutical Company Limited; Agensys, Inc.; Genmab A/S; Merck; and RemeGen, Co. Ltd. The company was formerly known as Seattle Genetics, Inc. and changed its name to Seagen Inc. in October 2020. Seagen Inc. was incorporated in 1997 and is headquartered in Bothell, Washington. As of December 14, 2023, Seagen Inc. operates as a subsidiary of Pfizer Inc.